HH
Houte Hans Van
DELAYED 1 MONTH
Chief Financial Officer
Nurix Therapeutics, Inc.
Filings
2
Companies
1
Latest
May 5, 2026
Transactions
Signal
Ticker / Company
Insider
Transaction
Value
Filed
64
NRIXCLUSTER 3
Nurix Therapeutics, Inc.
Hans Van Houte
Chief Financial Officer
Sale
$66.5K
2,845 sh
Jul 30 9:58 PM
Jul 30, 2026
—
Nurix Therapeutics, Inc.
Hans Van Houte
Chief Financial Officer
Option Exercise
—
10,180 sh
Jul 30 9:58 PM
Jul 30, 2026
70
Nurix Therapeutics, Inc.
Houte Hans Van
Chief Financial Officer
Sale
$233.3K
14,055 sh
May 5 11:53 PM
May 5, 2026
60
NRIXCLUSTER 3
Nurix Therapeutics, Inc.
Houte Hans Van
Chief Financial Officer
Sale
$39.7K
2,388 sh
Apr 30 9:38 PM
Apr 30, 2026
—
Nurix Therapeutics, Inc.
Houte Hans Van
Chief Financial Officer
Option Exercise
—
8,608 sh
Apr 30 9:38 PM
Apr 30, 2026